Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

511
The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
511
Peritoneum01:21

Peritoneum

7.3K
The peritoneum is a vital membrane that lines the abdominal cavity and covers most of the organs within it. It plays a crucial role in protecting the organs, providing a smooth surface for their movement, and facilitating various physiological processes. Understanding the anatomy and function of the peritoneum is essential for comprehending the complexities of the abdominal region.
Anatomy of the Peritoneum
The peritoneum is divided into two layers: the parietal peritoneum and the visceral...
7.3K
Pleura of the Lungs01:13

Pleura of the Lungs

5.7K
The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...
5.7K
Esophageal Perforation-I: Introduction01:22

Esophageal Perforation-I: Introduction

336
Esophageal perforation is a severe medical condition characterized by a breach in the integrity of the esophageal wall. This breach can occur due to various factors such as trauma, medical procedures, or underlying diseases. When the esophageal wall is compromised, it allows food, fluids, and digestive juices into the chest cavity or adjacent structures, leading to potential complications and health risks.
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
336
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

360
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
360

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Model for Clinician and Staff Education in the Engagement of American Indians in Genomic Research.

Journal of cancer education : the official journal of the American Association for Cancer Education·2026
Same author

ASO Visual Abstract: Decision Regret and Burden in Caregivers of Patients with Appendiceal Cancer Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.

Annals of surgical oncology·2025
Same author

Decision Regret and Burden in Caregivers of Patients with Appendiceal Cancer Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.

Annals of surgical oncology·2025
Same author

Consensus guideline for the management of peritoneal mesothelioma.

Cancer·2025
Same author

Consensus Guideline for the Management of Peritoneal Mesothelioma.

Annals of surgical oncology·2025
Same author

Consensus Guideline for the Management of Malignant Gastrointestinal Obstruction in Patients with Peritoneal Surface Malignancies.

Annals of surgical oncology·2025
Same journal

Adjuvant epidermal growth factor receptor tyrosine kinase inhibitor in resected stage N2 non-small cell lung cancer harboring <i>EGFR</i> mutation.

Translational lung cancer research·2026
Same journal

Annual progress in transbronchial diagnosis and treatment of pulmonary malignant tumors [2025]: a narrative review.

Translational lung cancer research·2026
Same journal

Prognostic value of ROS1 rearrangement in lung adenocarcinoma stratified by clinicopathologic and radiological features: a retrospective cohort study.

Translational lung cancer research·2026
Same journal

Case report: first-line lorlatinib in metastatic lung adenocarcinoma with a novel WIPF1-ALK and EML4-ALK dual fusion.

Translational lung cancer research·2026
Same journal

Challenges for first-line therapy in elderly patients with metastatic non-small cell lung cancer.

Translational lung cancer research·2026
Same journal

Macrophages in lung cancer: principal factors, regulatory mechanisms, and therapeutic opportunities: a narrative review.

Translational lung cancer research·2026
See all related articles

Related Experiment Video

Updated: Dec 25, 2025

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

7.2K

Peritoneal mesothelioma.

Alissa Greenbaum1, H Richard Alexander1

  • 1Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.

Translational Lung Cancer Research
|March 25, 2020
PubMed
Summary
This summary is machine-generated.

Malignant peritoneal mesothelioma (MPM) is a rare cancer. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) offer survival benefits for resectable cases, while inoperable disease requires further research.

Keywords:
Mesotheliomacytoreductive surgery (CRS)peritoneal malignancy

More Related Videos

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

9.6K
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

2.2K

Related Experiment Videos

Last Updated: Dec 25, 2025

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

7.2K
Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

9.6K
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

2.2K

Area of Science:

  • Oncology
  • Surgical Oncology

Background:

  • Malignant peritoneal mesothelioma (MPM) is a rare, aggressive cancer of the peritoneum.
  • Disease progression causes significant morbidity, including bowel obstruction and cachexia.
  • Treatment options are limited, especially for inoperable cases.

Purpose of the Study:

  • To review the current standard of care for MPM.
  • To highlight the role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC).
  • To discuss challenges and future research directions for MPM treatment.

Main Methods:

  • Review of existing literature and treatment guidelines for MPM.
  • Analysis of outcomes for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC).
  • Discussion of systemic treatment limitations and emerging therapeutic targets.

Main Results:

  • Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) can achieve >5-year survival in selected patients with resectable MPM.
  • MPM is often refractory to standard systemic chemotherapy regimens.
  • High-volume centers and clinical trial participation are crucial for optimal patient management.

Conclusions:

  • Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is the standard of care for resectable MPM.
  • Further research into genetic/immunologic targets and surgical refinement is essential for improving outcomes in inoperable MPM.
  • Multidisciplinary care at specialized centers is recommended for MPM patients.